Search Results
Found 1 results
510(k) Data Aggregation
(549 days)
DIAZYME D-DIMER ASSAY KIT,CALIBRATOR SETAND CONTROL SET
The D-Dimer Assay is for the quantitative determination of fibrin degradation products (D-Dimer) in human plasma. Measurement of D-Dimer is used as an aid in detecting the presence of intravascular coagulation and fibrinolysis. For in vitro diagnostic use only.
The Diazyme D-Dimer Calibrator Set is intended for use of the calibration of the Diazyme D-Dimer Assay only. For in vitro diagnostic use only.
The Diazyme D-Dimer Control Set is intended for use as quantitative quality controls for the Diazyme D-Dimer Assay only. For in vitro diagnostic use only.
Diazyme's D-Dimer Assay is based on a latex enhanced immunoturbidimetric assay. D-Dimer proteins in the sample bind to the specific anti-D-Dimer antibody, which is coated on latex particles, and causes agglutination. The degree of the turbidity caused by agglutination can be measured optically and is proportional to the amount of D-Dimer in the sample. The instrument calculates the D-Dimer concentration of a patient specimen by interpolation of the obtained signal of a 6-point calibration curve.
Here's a breakdown of the acceptance criteria and study information for the Diazyme D-Dimer Assay Kit, Diazyme D-Dimer Assay Calibrator Set, and Diazyme D-Dimer Assay Control Set, based on the provided 510(k) summary:
1. Table of Acceptance Criteria and Reported Device Performance
Performance Metric | Acceptance Criteria (Implicit from Predicate) | Reported Device Performance (Diazyme D-Dimer Assay) |
---|---|---|
Linear Range | 0.15 - 9 µg/mL FEU D-Dimer (Predicate: Roche Tina-Quant D-Dimer K062203) | 0.15 - 8 µg/mL FEU D-Dimer |
Precision (CV%) | 0.8 - 8.3% (Predicate: Roche Tina-Quant D-Dimer K062203) | Internal Study: |
- Plasma Samples Within Run: 1.4% - 5.0%
- Plasma Samples Total: 2.7% - 6.2%
- Control Samples Within Run: 1.4% - 2.9%
- Control Samples Total: 2.8% - 4.4%
External Study: - Total CV%: 3.5% - 11.5% |
| Correlation Coefficient (Method Comparison) | 0.775 (Predicate: vs. Asserachrom D-Dimer K862156) | 0.939 (vs. Roche Tina-Quant D-Dimer K062203) |
| Slope (Method Comparison) | 1.03 (Predicate: vs. Asserachrom D-Dimer K862156) | 0.979 (vs. Roche Tina-Quant D-Dimer K062203) |
| Intercept (Method Comparison) | -0.11 (Predicate: vs. Asserachrom D-Dimer K862156) | -0.106 (vs. Roche Tina-Quant D-Dimer K062203) |
| Bias around medical decision point | Not explicitly stated for predicate in summary, but typical for method comparison studies. | -0.12 µg/mL FEU |
| Limit of Blank (LOB) | Not explicitly stated for predicate. | 0.06 µg/mL FEU |
| Limit of Detection (LOD) | Not explicitly stated for predicate. | 0.09 µg/mL FEU |
| Limit of Quantitation (LOQ) | Not explicitly stated for predicate. | 0.15 µg/mL FEU (target CV
Ask a specific question about this device
Page 1 of 1